Your browser doesn't support javascript.
loading
MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa, Kazuya; Lyu, Jiajun; Kubo, Takuya; Tanaka, Yuki; Suzuki, Akane; Horie, Tetsuhiro; Tomizawa, Akane; Osumi, Ryoma; Iwahashi, Sayuki; Tokumura, Kazuya; Murata, Misato; Kobayashi, Masaki; Todo, Tomoki; Hirao, Atsushi; Hinoi, Eiichi.
Affiliation
  • Fukasawa K; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Lyu J; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Kubo T; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Tanaka Y; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Suzuki A; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Horie T; Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan.
  • Tomizawa A; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Osumi R; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Iwahashi S; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Tokumura K; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Murata M; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Kobayashi M; Laboratory of Pharmacology, Department of Bioactive Molecules, Gifu Pharmaceutical University, Gifu, Japan.
  • Todo T; Division of Innovative Cancer Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Hirao A; WPI Nano Life Science Institute (WPI-Nano LSI), Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Hinoi E; Cancer and Stem Cell Research Program, Division of Molecular Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
Cancer Res Commun ; 3(1): 148-159, 2023 01.
Article in En | MEDLINE | ID: mdl-36968222
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Commun Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Res Commun Year: 2023 Document type: Article Affiliation country: Country of publication: